Jari Helin

Glykos (Finland) — Finland

Biochemistry, Genetics and Molecular Biology · Life Sciences

27h-index3.0kcitations111works0.32yr avg

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glycosylation and Glycoproteins Research(41), Angiogenesis and VEGF in Cancer(35), HER2/EGFR in Cancer Research(34), Carbohydrate Chemistry and Synthesis(23), Cancer Treatment and Pharmacology(22)

Publications111 total

Supplementary Table 6 from Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves In Vivo Efficacy and Tolerability

2024Open Access

Supplementary Figure 7 from Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves In Vivo Efficacy and Tolerability

2024Open Access

Supplementary Figure 6 from Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves In Vivo Efficacy and Tolerability

2024Open Access

Supplementary Table 7 from Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves In Vivo Efficacy and Tolerability

2024Open Access

Supplementary Table 2 from Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves In Vivo Efficacy and Tolerability

2024Open Access

Supplementary Table 4 from Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves In Vivo Efficacy and Tolerability

2024Open Access

Supplementary Figure 1 from Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves In Vivo Efficacy and Tolerability

2024Open Access

Supplementary Table 1 from Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves In Vivo Efficacy and Tolerability

2024Open Access

Supplementary Figure 8 from Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves In Vivo Efficacy and Tolerability

2024Open Access

Supplementary Figure 3 from Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves In Vivo Efficacy and Tolerability

2024Open Access

Supplementary Figure 14 from Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves In Vivo Efficacy and Tolerability

2024Open Access

Supplementary Figure 2 from Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves In Vivo Efficacy and Tolerability

2024Open Access

Supplementary Figure 4 from Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves In Vivo Efficacy and Tolerability

2024Open Access

Supplementary Figure 13 from Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves In Vivo Efficacy and Tolerability

2024Open Access

Supplementary Table 3 from Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves In Vivo Efficacy and Tolerability

2024Open Access

Supplementary Table 5 from Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves In Vivo Efficacy and Tolerability

2024Open Access

Supplementary Figure 5 from Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves In Vivo Efficacy and Tolerability

2024Open Access

Supplementary Figure 11 from Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves In Vivo Efficacy and Tolerability

2024Open Access

Data from Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves In Vivo Efficacy and Tolerability

2024Open Access

Supplementary Figure 10 from Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves In Vivo Efficacy and Tolerability

2024Open Access

page 1 of 6Next →

Frequent Co-authors

Ossi Renkonen(14), Nisse Kalkkinen(12), Anne Leppänen(11), Hannu Maaheimo(11), Juhani Saarinen(8), Leena Penttilä(8), Ritva Niemelä(7), Catherine E. Costello(6), Jari Natunen(6), Tero Satomaa(6), Antti Seppo(6), Risto Renkonen(5), Raimo Mikkola(4), Mirja Salkinoja‐Salonen(4), Olli Aitio(4), Anja Vilkman(4), Richard D. Cummings(3), Timo Palosuo(3), Jarkko Räbinä(3), Henna Pynnönen(3)